Celsa Spina

Title(s)Associate Adjunct Professor, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Use of Protein Biomarkers to Identify Latent/Persistent HIV Infected Cell Reservoirs Without Induced Reactivation
    NIH R21AI122389Aug 15, 2016 - Jan 31, 2019
    Role: Principal Investigator
    Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication
    NIH R33AI104282Feb 1, 2013 - Jun 30, 2020
    Role: Principal Investigator
    Control of Latent/Persistent HIV Infection in Primary CD4 T Cells
    NIH I01BX001160Jul 1, 2011 - Jun 30, 2015
    Role: Principal Investigator
    MoFlo XDP High Speed Cell Sorter
    NIH S10RR027933May 20, 2010 - May 19, 2011
    Role: Principal Investigator
    Global Gene Regulation in CD4 T Cell Signaling
    NIH R21AI055388Apr 15, 2003 - Mar 31, 2006
    Role: Principal Investigator
    LYMPHOCYTE RESPONSE AND REGULATION IN HERPES INFECTION
    NIH R23AI019952Jun 1, 1983 - Jul 31, 1986
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells. PLoS One. 2022; 17(7):e0271674. Soto PC, Terry VH, Lewinski MK, Deshmukh S, Beliakova-Bethell N, Spina CA. PMID: 35895672; PMCID: PMC9328514.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    2. Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency. Virology. 2022 08; 573:50-58. Beliakova-Bethell N, Manousopoulou A, Deshmukh S, Mukim A, Richman DD, Garbis SD, Spina CA. PMID: 35714458; PMCID: PMC10427345.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    3. Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control. AIDS Res Hum Retroviruses. 2021 02; 37(2):109-121. Heinson AI, Woo J, Mukim A, White CH, Moesker B, Bosque A, Spina CA, Woelk CH, Macarthur BD, Beliakova-Bethell N. PMID: 33045840; PMCID: PMC7876363.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    4. Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal. PLoS One. 2019; 14(11):e0224879. Trypsteen W, White CH, Mukim A, Spina CA, De Spiegelaere W, Lefever S, Planelles V, Bosque A, Woelk CH, Vandekerckhove L, Beliakova-Bethell N. PMID: 31710657; PMCID: PMC6844474.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    5. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy. J Virol. 2019 07 01; 93(13). Christensen-Quick A, Massanella M, Frick A, Rawlings SA, Spina C, Vargas-Meneses M, Schrier R, Nakazawa M, Anderson C, Gianella S. PMID: 31019052; PMCID: PMC6580967.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    6. Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation. J Biol Chem. 2019 04 05; 294(14):5576-5589. Beliakova-Bethell N, Mukim A, White CH, Deshmukh S, Abewe H, Richman DD, Spina CA. PMID: 30745362; PMCID: PMC6462528.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    7. Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol. 2018; 9:603. White CH, Beliakova-Bethell N, Lada SM, Breen MS, Hurst TP, Spina CA, Richman DD, Frater J, Magiorkinis G, Woelk CH. PMID: 29706951; PMCID: PMC5906534.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    8. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology. 2017 08; 508:127-133. Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman DD, Spina CA. PMID: 28527342; PMCID: PMC5654527.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    9. HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. HIV Clin Trials. 2017 03; 18(2):67-74. Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S, California Collaborative Treatment Group (CCTG) 589 Study Team. PMID: 28134057; PMCID: PMC5613656.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    10. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog. 2016 Nov; 12(11):e1006026. White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman DD, Planelles V, Bosque A, Woelk CH. PMID: 27898737; PMCID: PMC5127598.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    11. Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):133-7. Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S. PMID: 26818740; PMCID: PMC4868660.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    12. Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1. J Virol. 2015 Dec 16; 90(5):2486-502. Tokarev A, Stoneham C, Lewinski MK, Mukim A, Deshmukh S, Vollbrecht T, Spina CA, Guatelli J. PMID: 26676780; PMCID: PMC4810708.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    13. Dose-responsive gene expression in suberoylanilide hydroxamic acid-treated resting CD4+ T cells. AIDS. 2015 Nov; 29(17):2235-44. Reardon B, Beliakova-Bethell N, Spina CA, Singhania A, Margolis DM, Richman DR, Woelk CH. PMID: 26258524; PMCID: PMC4917679.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    14. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency. Antiviral Res. 2015 Nov; 123:78-85. White CH, Johnston HE, Moesker B, Manousopoulou A, Margolis DM, Richman DD, Spina CA, Garbis SD, Woelk CH, Beliakova-Bethell N. PMID: 26343910; PMCID: PMC5606336.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    15. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS One. 2015; 10(2):e0116526. Schrier RD, Hong S, Crescini M, Ellis R, Pérez-Santiago J, Spina C, Letendre S, HNRP Group. PMID: 25719800; PMCID: PMC4342256.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    16. Sulfonation pathway inhibitors block reactivation of latent HIV-1. Virology. 2014 Dec; 471-473:1-12. Murry JP, Godoy J, Mukim A, Swann J, Bruce JW, Ahlquist P, Bosque A, Planelles V, Spina CA, Young JA. PMID: 25310595; PMCID: PMC4392775.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    17. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol. 2014 Jul; 88(14):7818-27. Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM, California Collaborative Treatment Group 592 Team. PMID: 24789781; PMCID: PMC4097769.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    18. Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression. Antiviral Res. 2014 Jul; 107:42-9. Beliakova-Bethell N, Jain S, Woelk CH, Witt MD, Sun X, Lada SM, Spina CA, Goicoechea M, Rought SE, Haubrich R, Dubé MP. PMID: 24769244; PMCID: PMC4116489.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    19. Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing. PLoS Pathog. 2014 Apr; 10(4):e1004071. Wei DG, Chiang V, Fyne E, Balakrishnan M, Barnes T, Graupe M, Hesselgesser J, Irrinki A, Murry JP, Stepan G, Stray KM, Tsai A, Yu H, Spindler J, Kearney M, Spina CA, McMahon D, Lalezari J, Sloan D, Mellors J, Geleziunas R, Cihlar T. PMID: 24722454; PMCID: PMC3983056.
      View in: PubMed   Mentions: 172     Fields:    Translation:HumansCellsCTClinical Trials
    20. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS. 2014 Mar 27; 28(6):841-9. Karris MY, Kao YT, Patel D, Dawson M, Woods SP, Vaida F, Spina C, Richman D, Little S, Smith DM. PMID: 24401640; PMCID: PMC4049563.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    21. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog. 2013; 9(12):e1003834. Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V. PMID: 24385908; PMCID: PMC3873446.
      View in: PubMed   Mentions: 273     Fields:    Translation:HumansCells
    22. The effect of cell subset isolation method on gene expression in leukocytes. Cytometry A. 2014 Jan; 85(1):94-104. Beliakova-Bethell N, Massanella M, White C, Lada S, Du P, Vaida F, Blanco J, Spina CA, Woelk CH. PMID: 24115734; PMCID: PMC3975050.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    23. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS. 2013 Jul 31; 27(12):1921-31. Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman DD, Smith DM. PMID: 24180001; PMCID: PMC3816380.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    24. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One. 2013; 8(4):e55943. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. PMID: 23573183; PMCID: PMC3616050.
      View in: PubMed   Mentions: 269     Fields:    Translation:HumansCells
    25. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells. AIDS. 2013 Jan 02; 27(1):29-37. Beliakova-Bethell N, Zhang JX, Singhania A, Lee V, Terry VH, Richman DD, Spina CA, Woelk CH. PMID: 23221426; PMCID: PMC3752851.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    26. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. AIDS. 2013 Jan 02; 27(1):39-47. Gianella S, Morris SR, Anderson C, Spina CA, Vargas MV, Young JA, Richman DD, Little SJ, Smith DM. PMID: 22739399; PMCID: PMC3769229.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    27. Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infection. Biomed Res Int. 2013; 2013:796014. Marcondes MC, Spina C, Bustamante E, Fox H. PMID: 23484159; PMCID: PMC3591242.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    28. Microwell devices with finger-like channels for long-term imaging of HIV-1 expression kinetics in primary human lymphocytes. Lab Chip. 2012 Nov 07; 12(21):4305-12. Razooky BS, Gutierrez E, Terry VH, Spina CA, Groisman A, Weinberger LS. PMID: 22976503; PMCID: PMC3589574.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    29. Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells. J Mol Med (Berl). 2013 Feb; 91(2):261-70. Soto PC, Karris MY, Spina CA, Richman DD, Varki A. PMID: 22945238; PMCID: PMC3558668.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    30. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol. 2012 Feb; 86(3):1307-15. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, Spina CA, Smith DM. PMID: 22114342; PMCID: PMC3264378.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    31. Flow cytometric screening for anti-leishmanials in a human macrophage cell line. Exp Parasitol. 2010 Dec; 126(4):617-20. Mehta SR, Zhang XQ, Badaro R, Spina C, Day J, Chang KP, Schooley RT. PMID: 20540940; PMCID: PMC2939291.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    32. Prevalence and T-cell phenotype of slow HIV disease progressors with robust HIV replication. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):299-301. Goicoechea M, Smith D, May S, Mathews C, Spina C. PMID: 20118679; PMCID: PMC2818087.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. CD44 microbeads accelerate HIV-1 infection in T cells. Virology. 2009 Jun 05; 388(2):294-304. Terry VH, Johnston IC, Spina CA. PMID: 19394995; PMCID: PMC2699902.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    34. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 01; 197(3):411-9. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. PMID: 18248304.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    35. Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro. Clin Vaccine Immunol. 2006 Nov; 13(11):1223-30. Stone GW, Barzee S, Snarsky V, Spina CA, Lifson JD, Pillai VK, Amara RR, Villinger F, Kornbluth RS. PMID: 16988005; PMCID: PMC1656546.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    36. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol. 2006 Feb; 80(4):1762-72. Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, Kornbluth RS. PMID: 16439533; PMCID: PMC1367159.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    37. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005 Aug 13-19; 366(9485):549-55. Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. PMID: 16099290; PMCID: PMC1894952.
      View in: PubMed   Mentions: 250     Fields:    Translation:HumansCells
    38. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCells
    39. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004 Dec 20; 200(12):1547-57. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman DD, McMichael AJ, Jones EY, Rowland-Jones SL. PMID: 15596521; PMCID: PMC2212004.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    40. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004 Feb; 2(2):E20. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V. PMID: 14966528; PMCID: PMC340937.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCells
    41. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4819-24. Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK. PMID: 12684537; PMCID: PMC153639.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    42. Dynamics of T cell responses in HIV infection. J Immunol. 2002 Apr 01; 168(7):3660-6. Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, Ogg GS, Little S, McMichael AJ, Richman DD, Rowland-Jones SL. PMID: 11907132.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    43. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002 Apr; 8(4):379-85. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. PMID: 11927944.
      View in: PubMed   Mentions: 567     Fields:    Translation:HumansCells
    44. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA. PMID: 11807299.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    45. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000 Jul 03; 192(1):63-75. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL. PMID: 10880527; PMCID: PMC1887711.
      View in: PubMed   Mentions: 253     Fields:    Translation:HumansCells
    46. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis. 2000 Feb; 181(2):522-31. Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD. PMID: 10669335.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsPHPublic Health
    47. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol. 1999 Nov; 73(11):9404-12. Günthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK. PMID: 10516049; PMCID: PMC112975.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    48. Viral dynamics of acute HIV-1 infection. J Exp Med. 1999 Sep 20; 190(6):841-50. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. PMID: 10499922; PMCID: PMC2195636.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCells
    49. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997 Nov 14; 278(5341):1291-5. Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. PMID: 9360926.
      View in: PubMed   Mentions: 962     Fields:    Translation:HumansCells
    50. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J Clin Invest. 1997 Apr 01; 99(7):1774-85. Spina CA, Prince HE, Richman DD. PMID: 9120023; PMCID: PMC507999.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    51. Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center. J Clin Invest. 1996 Aug 01; 98(3):731-40. Schrier RD, Wiley CA, Spina C, McCutchan JA, Grant I. PMID: 8698865; PMCID: PMC507483.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    52. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol. 1996 Jul; 70(7):4283-90. Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC. PMID: 8676450; PMCID: PMC190360.
      View in: PubMed   Mentions: 91     Fields:    Translation:Cells
    53. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology. 1995 Oct 01; 212(2):451-7. Chowers MY, Pandori MW, Spina CA, Richman DD, Guatelli JC. PMID: 7571414.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    54. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol. 1995 May; 69(5):2977-88. Spina CA, Guatelli JC, Richman DD. PMID: 7707524; PMCID: PMC188997.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    55. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1. Virology. 1994 Dec; 205(2):578-82. Little SJ, Riggs NL, Chowers MY, Fitch NJ, Richman DD, Spina CA, Guatelli JC. PMID: 7975260.
      View in: PubMed   Mentions: 19     Fields:    Translation:Cells
    56. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol. 1994 May; 68(5):2906-14. Chowers MY, Spina CA, Kwoh TJ, Fitch NJ, Richman DD, Guatelli JC. PMID: 8151761; PMCID: PMC236779.
      View in: PubMed   Mentions: 200     Fields:    Translation:HumansCells
    57. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med. 1994 Jan 01; 179(1):115-23. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD. PMID: 7903679; PMCID: PMC2191324.
      View in: PubMed   Mentions: 174     Fields:    Translation:HumansCells
    58. In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism. Virology. 1993 Mar; 193(1):256-67. Meylan PR, Spina CA, Richman DD, Kornbluth RS. PMID: 8438570.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    59. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature. 1990 Sep 06; 347(6288):92-5. Zarling JM, Moran PA, Haffar O, Sias J, Richman DD, Spina CA, Myers DE, Kuebelbeck V, Ledbetter JA, Uckun FM. PMID: 1975641.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    60. Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicity. Cancer Res. 1988 Oct 15; 48(20):5853-9. Lichtenstein A, Spina C, Berek JS, Jung T, Zighelboim J. PMID: 3167841.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    61. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Res. 1981 Nov; 41(11 Pt 1):4324-30. Spina CA, Dorey F, Vescera C, Brosman S, Fahey JL. PMID: 6458353.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    62. Altered cellular immune functions in patients with Down's syndrome. Am J Dis Child. 1981 Mar; 135(3):251-5. Spina CA, Smith D, Korn E, Fahey JL, Grossman HJ. PMID: 6452055.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    63. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus. J Infect Dis. 1976 Jun; 133(6):676-80. Chang RS, Spina CA. PMID: 180190.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    64. Suppression of spontaneous in vitro transformation of autologous leukocytes by plasma from convalescent and postconvalescent infectious mononucleosis patients. J Natl Cancer Inst. 1975 Oct; 55(4):803-5. Chang RS, Spina CA. PMID: 171425.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    Celsa's Networks
    Concepts (320)
    Derived automatically from this person's publications.
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _